Loading logo

Teriflunomide Impurities

Teriflunomide is an immunomodulatory drug primarily used in the treatment of relapsing forms of multiple sclerosis (MS), helping to reduce the frequency of flare-ups and slow disease progression. It works by inhibiting pyrimidine synthesis through selective blocking of the enzyme dihydroorotate dehydrogenase, thereby reducing the proliferation of activated T and B lymphocytes. Maintaining the pharmaceutical purity of Teriflunomide is essential to ensure its therapeutic efficacy, patient safety, and adherence to regulatory standards. Impurity profiling is crucial to detect and control unwanted by-products that may arise during manufacturing, storage, or degradation. Here are some of its known impurities listed below.

Showing 1 - 5 of 5 products
Teriflunomide (E)-Isomer
Catalogue No : TERI-OCL-001

CAS No : N/A

In Stock
Synonyms
Leflunomide Cyano (E)-Isomer (E)-2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
Teriflunomide (Z-Isomer)
Catalogue No : TERI-OCL-004

CAS No : 163451-81-8

In Stock
Synonyms
Leflunomide EP Impurity B Leflunomide USP RC B
Teriflunomide (Z/E )
Catalogue No : TERI-OCL-005

CAS No : 108605-62-5

In Stock
Synonyms
2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)crotonamide
Teriflunomide 2-Oxo-Acetic Acid Impurity
Catalogue No : TERI-OCL-002

CAS No : 69066-42-8

In Stock
Synonyms
2-Oxo-2-(4-(trifluoromethyl)phenylamino)acetic acid
Teriflunomide 4-Hydroxy
Catalogue No : TERI-OCL-003

CAS No : 1058722-45-4

In Stock
Synonyms
(2Z)-2-Cyano-3,4-dihydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide